MLST typing of Escherichia coli isolates overproducing AmpC -lactamase
Author(s) -
A. Guillouzouic,
Nathalie Caroff,
Sandie Dauvergne,
Didier Lepelletier,
Agnès PerrinGuyomard,
Isabelle Kempf,
Alain Reynaud,
Stéphane Corvec
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp099
Subject(s) - escherichia coli , overproduction , microbiology and biotechnology , biology , bacteria , pathogen , rna polymerase , homology (biology) , cephalosporin , multilocus sequence typing , gene , genetics , antibiotics , genotype
Escherichia coli is the major commensal aerobic bacterium of the digestive tract of humans and animals, but is also the most frequent human bacterial pathogen. As a consequence, resistance mechanisms carried by this species are of particular concern. One of these mechanisms is the overproduction of the chromosomal AmpC β-lactamase, leading to increased MICs of most β-lactams including third-generation cephalosporins. AmpC overproduction is caused by various mutations in the ampC promoter (–42, –32 and –11) increasing homology with the consensus promoter for RNA polymerase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom